The cardiovascular and cardiac actions of ecstasy and its metabolites.
Study Goal
The researchers aimed to review the literature on MDMA's cardiovascular effects and toxicity, focusing on mechanisms and clinical implications.
Results Summary
The study found that MDMA causes significant neurotoxicity and cardiovascular toxicity, including rhythm disturbances, infarction, and sudden death, with oxidative stress and redox-active metabolites playing key roles.
Population
Humans and experimental animals (not specified further).
Effective Dosage
Not specified.
Duration
Not specified.
Interactions
None mentioned.
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
3, 4 methylenedioxymethamphetamine (ecstasy or MDMA) | increase | stamina | - | - | increase | #1 |
3, 4 methylenedioxymethamphetamine (ecstasy or MDMA) | increase | feelings of emotional closeness and wellbeing | - | - | produce | #2 |
3, 4 methylenedioxymethamphetamine (ecstasy or MDMA) | decrease | serotonergic and catecholaminergic systems | - | - | produce significant neurotoxicity | #3 |
3, 4 methylenedioxymethamphetamine (ecstasy or MDMA) | neutral | cardiovascular function | - | - | alter | #4 |
3, 4 methylenedioxymethamphetamine (ecstasy or MDMA) | increase | rhythm disturbances, infarction and sudden death | - | - | produce cardiac toxicity | #5 |
oxidative stress | neutral | cardiotoxic actions of MDMA | - | - | plays an important role in the cardiotoxic actions | #6 |
redox active metabolites of MDMA | neutral | MDMA induced toxicity | - | - | play especially important roles | #7 |
The recreational use of 3, 4 methylenedioxymethamphetamine (ecstasy or MDMA) has increased dramatically over the past thirty years due to its ability to increase stamina and produce feelings of emotional closeness and wellbeing. In spite of the popular perception that MDMA is a safe drug, there is a large literature documenting that the drug can produce significant neurotoxicity, especially in serotonergic and catecholaminergic systems. There are also experimental and clinical data which document that MDMA can alter cardiovascular function and produce cardiac toxicity, including rhythm disturbances, infarction and sudden death. This manuscript will review the literature documenting the cardiovascular responses elicited by MDMA in humans and experimental animals and will examine the underlying mechanisms mediating these responses. We will also review the available clinical, autopsy and experimental data linking MDMA with cardiac toxicity. Most available data indicate that oxidative stress plays an important role in the cardiotoxic actions of MDMA. Moreover, new data indicates that redox active metabolites of MDMA may play especially important roles in MDMA induced toxicity.